Vimian Group
40.85
SEK
-2.97 %
VIMIAN
First North Stockholm
Health Care Providers
Health Care
5 following
-2.97%
-7.16%
-6.31%
+17.55%
+42.53%
+49.71%
-42.09%
-
-47.85%
Vimian Group is a group active in animal health. Through its subsidiaries, the company delivers medicines and technical solutions to veterinarians, laboratories, and pet owners. The products include, for example, drugs with associated clinical research and digital platforms for veterinary clinics. The company operates worldwide and is headquartered in Stockholm.
Read moreMarket cap
21.4B SEK
Turnover
4.18M SEK
Revenue
3.69B
EBIT %
12.44 %
P/E
183.45
Dividend yield-%
-
Financial calendar
13/2
2025
Annual report '24
29/4
2025
General meeting '24
29/4
2025
Interim report Q1'25
ShowingAll content types
Vimian’s Interim Report for the third quarter of 2024
Vimians delårsrapport för det tredje kvartalet 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Invitation to Vimian’s Interim Report for the third quarter of 2024
Inbjudan till Vimians delårsrapport för tredje kvartalet 2024
Nomination Committee for Vimian’s 2025 Annual General Meeting
Valberedning inför Vimians årsstämma 2025
Vimian Group to enter new MedTech niche through the acquisition of a global veterinary dental company
Vimian Group går in i ny MedTech nisch genom förvärvet av globalt företag inom veterinärmedicinsk tandvård
